To include your compound in the COVID-19 Resource Center, submit it here.

Idec licenses cancer compound

IDPH received from Nippon Shinyaku (Kyoto, Japan) a global license

Read the full 103 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE